Trans-Plasma Membrane Electron Transport in Mammals: Functional Significance in Health and Disease
- 1 June 2011
- journal article
- review article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 14 (11) , 2289-2318
Abstract
Trans-plasma membrane electron transport (t-PMET) has been established since the 1960s, but it has only been subject to more intensive research in the last decade. The discovery and characterization at the molecular level of its novel components has increased our understanding of how t-PMET regulates distinct cellular functions. This review will give an update on t-PMET, with particular emphasis on how its malfunction relates to some diseases, such as cancer, abnormal cell death, cardiovascular diseases, aging, obesity, neurodegenerative diseases, pulmonary fibrosis, asthma, and genetically linked pathologies. Understanding these relationships may provide novel therapeutic approaches for pathologies associated with unbalanced redox state. Antioxid. Redox Signal. 14, 2289–2318.Keywords
This publication has 311 references indexed in Scilit:
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Nox proteins in signal transductionFree Radical Biology and Medicine, 2009
- Caspases and Kinases in a Death GripCell, 2009
- NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injuryNature Medicine, 2009
- Regulation of cancer cell metabolism by hypoxia-inducible factor 1Seminars in Cancer Biology, 2009
- Autophagy fights disease through cellular self-digestionNature, 2008
- Uptake and reduction of α-lipoic acid by human erythrocytesClinical Biochemistry, 2007
- NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generationBiochemical Journal, 2007
- Endogenous synthesis of coenzyme Q in eukaryotesMitochondrion, 2007
- Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell deathNature Cell Biology, 2007